FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

New quick testing option to help reduce need for CT scans, radiation exposure for patients SILVER SPRING, Md., Feb. 14, 2018 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults. The FDA reviewed and authorized…